poisar

Stocks · News reference

8-K filing — Aspire Biopharma Holdings, Inc. (ASBPW)

Aug 19, 2026, 12:30 PMSEC EDGAR

Filed: 2026-08-19 AccNo: 0001493152-26-039135 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ASBPW
Source
edgar
Observed
Aug 19, 2026, 12:30 PM
Checked
Aug 19, 2026, 12:30 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Jun 17, 2026, 2:57 PMNa

    Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th

    Aspire Biopharma Holdings (ASBP) announced it will present live at the Life Sciences Investor Forum on June 25th, 2026. The company highlighted its multiple prescription applications in cardiovascular and other therapeutic areas, its lead drug candidate high-dose aspirin product, and the commercial launch of BUZZ BOMB caffeine product. Aspire also announced a proposed acquisition of Dura Driver Control Systems, expected to close in Q3 2026.

    Read original at globenewswire-inc
    ASBPASBPW